Trace Neuroscience Launches with $101 Million Series A Financing to Expand Genomic Medicine for Neurodegenerative Diseases, ...

Trace Neuroscience has launched in the U.S. with over $100 million in financing and a goal to develop its UNC13A-targeted treatment for ALS.

Brain aging has been a subject of fascination and inquiry for decades, and a 25-year research program has now unveiled ...

Scientists have developed a new brain-mapping tool called START, which combines transcriptomics and viral tracing to map the connections between specific neuronal subtypes with unprecedented detail.

If we’re hallucinating, we may not be hallucinating exactly the same thing.

Nov. 12, 2024 — Glioblastoma is the most common kind of malignant brain tumor in adults. So far, no treatment has been able to make this aggressive tumor permanently disappear. The tumor cells ...

These peel-and-stick sheets are great if you're a renter, as they won't leave a trace when it's time to move out and you need ...

Results of research in mice may provide potential avenues for therapeutic interventions in stress-related disorders.

Almost all cases of ALS and half of frontotemporal dementia (FTD) cases are linked to dysfunction in a protein TDP-43.